Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 9.75
-0.42 (-4.13%)
Jun 4, 2026, 3:00 PM CST
Shenzhen YHLO Biotech Revenue
Shenzhen YHLO Biotech had revenue of 397.82M CNY in the quarter ending March 31, 2026, a decrease of -4.78%. This brings the company's revenue in the last twelve months to 1.79B, down -10.38% year-over-year. In the year 2025, Shenzhen YHLO Biotech had annual revenue of 1.81B, down -9.99%.
Revenue (ttm)
1.79B
Revenue Growth
-10.38%
P/S Ratio
3.11
Revenue / Employee
1.08M
Employees
1,664
Market Cap
5.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81B | -200.99M | -9.99% |
| Dec 31, 2024 | 2.01B | -41.48M | -2.02% |
| Dec 31, 2023 | 2.05B | -1.93B | -48.42% |
| Dec 31, 2022 | 3.98B | 2.80B | 237.95% |
| Dec 31, 2021 | 1.18B | 178.89M | 17.91% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Huakang Century Clean Technology | 2.40B |
| INKON Life Technology | 1.97B |
| Guangdong Biolight Meditech | 1.10B |
| Shenzhen Lifotronic Technology | 1.08B |
| Shanghai Kinetic Medical | 869.21M |
| Hangzhou AGS MedTech | 605.58M |
| Shanghai Sanyou Medical | 549.93M |
| Nanjing Vishee Medical Technology | 472.85M |
Shenzhen YHLO Biotech News
- 5 weeks ago - Shenzhen YHLO Biotech Annual report: H2 2025 - Filings
- 5 weeks ago - Shenzhen YHLO Biotech Quarterly report: Q1 2026 - Filings
- 7 months ago - Shenzhen YHLO Biotech Quarterly report: Q3 2025 - Filings
- 10 months ago - Shenzhen YHLO Biotech Quarterly report: H1 2025 - Filings